| WILEX AG: Redectane meets both endpoints specificity and sensitivity with ... - PharmaLive.com (press release) |
|
|
PharmaLive.com (press release)In contrast to the preliminary data published in November 2009, the endpoint sensitivity, the correct diagnosis that clear cell renal cell cancer is present ... read more |